IL31 and atopic eczema: Within the study, interleukin-31 levels were measured in serum and cerebrospinal fluid samples of dogs affected by SRMA in comparison to dogs with atopic dermatitis (positive control), healthy dogs (negative control) and dogs with immune-mediated or infectious meningoencephalitis.